Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperglycemia × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Solid Tumors 1 Prostatic Neoplasms 1 Inflammation 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Heart Failure 1 Cardiotoxicity 1

Interventions

Fulvestrant 2 Alpelisib 2 exemestane 1 dapagliflozin 1 Vildagliptin 1 Tamoxifen 1 Metformin 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04899349 2024-10-09

EPIK-B4

Novartis

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡